Back
Merus NV Vs. Apellis Pharmaceuticals Industry Stock Comparison
Buy
60
MRUS
Merus NV
Last Price:
$54.62
Seasonality Move:
4.77%
Sell
45
APLS
Apellis Pharmaceuticals
Last Price:
$18.84
Seasonality Move:
2.19%
Sell
45
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals [APLS] share price is $19.26. The Score for APLS is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
APLS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MRUS Stock Price Chart
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $19.26The current trend is relatively stagnant and APLS is experiencing buying pressure, which is a positive indicator for future bullish movement.
MRUS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.35 | Buy |
Relative Strength Index (14 RSI): | 58.04 | Buy |
Chaikin Money Flow: | 26552 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (42.27 - 56.87) | Buy |
Bollinger Bands (100): | (39.45 - 50.07) | Buy |
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.21 | Buy |
Relative Strength Index (14 RSI): | 55.41 | Buy |
Chaikin Money Flow: | 1032412 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (17 - 18.96) | Buy |
Bollinger Bands (100): | (18.09 - 27.37) | Sell |
MRUS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 56.75 | Sell |
20-day SMA: | 51.59 | Buy |
50-day SMA: | 45.78 | Buy |
200-day SMA: | 46.41 | Buy |
8-day EMA: | 55.49 | Sell |
20-day EMA: | 52.54 | Buy |
50-day EMA: | 48.33 | Buy |
200-day EMA: | 45.72 | Buy |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.15 | Buy |
20-day SMA: | 18.15 | Buy |
50-day SMA: | 18.54 | Buy |
200-day SMA: | 27.37 | Sell |
8-day EMA: | 19.04 | Buy |
20-day EMA: | 18.59 | Buy |
50-day EMA: | 19.5 | Sell |
200-day EMA: | 27.43 | Sell |
Merus NV Earnings Growth & MRUS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.34 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.99 per share, and an increase next year of $0.24 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.14 per share, and an increase next year of $1.12 per share.
Merus NV Technical Analysis
May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Apellis Pharmaceuticals Technical Analysis
May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |